KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Elanco Animal Health (ELAN) Tax Provisions (2017 - 2025)

Historic Tax Provisions for Elanco Animal Health (ELAN) over the last 9 years, with Q3 2025 value amounting to -$16.0 million.

  • Elanco Animal Health's Tax Provisions fell 10820.51% to -$16.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$52.0 million, marking a year-over-year decrease of 12512.08%. This contributed to the annual value of $150.0 million for FY2024, which is 31666.67% up from last year.
  • Elanco Animal Health's Tax Provisions amounted to -$16.0 million in Q3 2025, which was down 10820.51% from $14.0 million recorded in Q2 2025.
  • In the past 5 years, Elanco Animal Health's Tax Provisions ranged from a high of $195.0 million in Q3 2024 and a low of -$43.0 million during Q4 2024
  • Moreover, its 5-year median value for Tax Provisions was -$4.0 million (2022), whereas its average is $5.1 million.
  • Examining YoY changes over the last 5 years, Elanco Animal Health's Tax Provisions showed a top increase of 1960000.0% in 2024 and a maximum decrease of 50000.0% in 2024.
  • Quarter analysis of 5 years shows Elanco Animal Health's Tax Provisions stood at -$15.0 million in 2021, then crashed by 133.33% to -$35.0 million in 2022, then surged by 140.0% to $14.0 million in 2023, then tumbled by 407.14% to -$43.0 million in 2024, then skyrocketed by 62.79% to -$16.0 million in 2025.
  • Its last three reported values are -$16.0 million in Q3 2025, $14.0 million for Q2 2025, and -$7.0 million during Q1 2025.